Skip to main content
Clinical Trials/NCT02763917
NCT02763917
Active, not recruiting
Not Applicable

AIRWEIGHS: Investigating Obesity as a Susceptibility Factor for Air Pollution in Childhood Asthma

Johns Hopkins University1 site in 1 country198 target enrollmentAugust 1, 2016
ConditionsAsthma

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Asthma
Sponsor
Johns Hopkins University
Enrollment
198
Locations
1
Primary Endpoint
Maximum Symptom Days
Status
Active, not recruiting
Last Updated
7 months ago

Overview

Brief Summary

Background: Asthma and obesity are public health crises that have concurrently risen over the past decades, affecting millions of children in the United States and disproportionately affecting low-income minority children in urban areas. The same children at highest risk for asthma and obesity also have greater exposure to indoor and outdoor pollution. Emerging evidence suggests that obesity may confer increased susceptibility to health effects of air pollution.

Methods: Aiming to provide causal-level evidence of these observational findings, we propose a home intervention study to 1) test whether targeted reductions of indoor Particulate Matter (PM) concentrations improve the respiratory health of overweight inner-city children with asthma more than that of lean inner-city children with asthma and 2) investigate mediators of susceptibility to indoor PM among overweight versus lean children with asthma. We will accomplish these aims using a 1:1 randomized controlled trial of 200 children with persistent asthma (half normal weight, half overweight) living in Baltimore City. Participants will be randomized to receive either two active air purifiers containing high-efficiency particulate air (HEPA) filters or two sham air purifiers with their filters removed.

Implications: If the aforementioned observational findings are confirmed, implications will be directly relevant to the over 170 million children around the world now estimated to be overweight or obese.

Detailed Description

The primary object of this study is to determine the efficacy of a targeted environmental intervention among overweight inner city children as compared to normal weight inner city children with asthma. Specific Aim #1: To determine if overweight inner-city children, compared to lean inner-city children, have greater improvement in asthma with an air purifier intervention aimed at reducing indoor PM. Hypothesis 1: An intervention using HEPA filter air purifiers in the homes of inner-city children with asthma will be associated with greater respiratory improvement in overweight children than in normal weight children. Specific Aim #2a: To investigate mediators of susceptibility among overweight versus normal weight children with asthma. Hypothesis #2. Candidate mediators, including increases in a) tidal volume and thereby increases in doses of inhaled particles, b) inflammatory and oxidative stress responses, c) corticosteroid resistance, and d) sleep disordered breathing mediate increased susceptibility to indoor PM among overweight versus normal weight children with asthma. Children with asthma will be enrolled in the study for about 16 weeks. They will have three clinic visits, an overnight sleep study, and two home environmental assessments for one week each. They will have a home and clinical assessment before randomization and another home and clinical assessment about 12 weeks after randomization. The primary outcome measure is maximum number of asthma symptom days.

Registry
clinicaltrials.gov
Start Date
August 1, 2016
End Date
September 1, 2027
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 8-17 years of age
  • Persistent asthma (NAEPP criteria)
  • Exacerbation in previous 12 months
  • Spends ≥4 nights/week at home
  • No plans to move during the study

Exclusion Criteria

  • Significant pulmonary or cardiac disease
  • Home not appropriate candidate due to disrepair
  • Underweight, defined by BMI \<5th percentile

Outcomes

Primary Outcomes

Maximum Symptom Days

Time Frame: Baseline and about 12 weeks after the intervention

We have chosen symptoms based on the strong relationship between symptoms and PM observed in previous studies. Symptoms during the previous two weeks will be captured with standardized questions used in many inner-city asthma studies, including our own that detected a strong association between indoor PM and asthma symptoms. A 'maximum symptom days' variable will constructed as the maximum of the variables: days of slowed activity, days of wheezing, coughing or chest tightness when running or going upstairs, and nights of waking with asthma symptoms in the past two weeks. We will administer questionnaires to the primary caregiver of children 8-11 years and to both participant and caregiver for adolescents age 12-17. Previous studies have indicated concordance between adolescent and the caregiver responses, and we will collect data to assess concordance within our study population. Individual symptom variables will serve as secondary outcomes.

Secondary Outcomes

  • Asthma Symptoms(Baseline and about 12 weeks after the intervention)
  • Lung Function(Baseline and about 12 weeks after the intervention.)
  • Asthma Control(Baseline and about 12 weeks after the intervention)
  • FENO(Baseline and about 12 weeks after the intervention)
  • Health Care Utilization(Baseline and about 12 weeks after the intervention)

Study Sites (1)

Loading locations...

Similar Trials